Pooled Analysis of the Prognostic and Predictive Value of KRAS Mutation Status and Mutation Subtype in Patients with Non–Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Alona Zer, Frances A. Shepherd, Allan Hackshaw et al.|Journal of Thoracic Oncology|2015

Cited by 55